Anti-inflammatory properties of butyrate-producing atypical Escherichia coli in a murine colitis model
- PMID: 36366930
- PMCID: PMC10169521
- DOI: 10.5217/ir.2022.00112
Anti-inflammatory properties of butyrate-producing atypical Escherichia coli in a murine colitis model
Conflict of interest statement
Park J is an editorial board member of the journal but was not involved in the peer reviewer selection, evaluation, or decision process of this article. No other potential conflicts of interest relevant to this article were reported.
Figures

Similar articles
-
Sodium butyrate inhibits the NF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an IL-10 independent manner.Int Immunopharmacol. 2017 Oct;51:47-56. doi: 10.1016/j.intimp.2017.07.023. Epub 2017 Aug 10. Int Immunopharmacol. 2017. PMID: 28802151
-
Impact of short-chain fatty acid supplementation on gut inflammation and microbiota composition in a murine colitis model.J Nutr Biochem. 2022 Mar;101:108926. doi: 10.1016/j.jnutbio.2021.108926. Epub 2021 Nov 27. J Nutr Biochem. 2022. PMID: 34848335
-
Lactobacillus paracasei L9 improves colitis by expanding butyrate-producing bacteria that inhibit the IL-6/STAT3 signaling pathway.Food Funct. 2021 Nov 1;12(21):10700-10713. doi: 10.1039/d1fo02077c. Food Funct. 2021. PMID: 34605504
-
Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.Acta Biomed. 2018 Dec 17;89(9-S):153-157. doi: 10.23750/abm.v89i9-S.7911. Acta Biomed. 2018. PMID: 30561409 Free PMC article.
-
Typical and atypical enteropathogenic Escherichia coli.Emerg Infect Dis. 2002 May;8(5):508-13. doi: 10.3201/eid0805.010385. Emerg Infect Dis. 2002. PMID: 11996687 Free PMC article. Review.
Cited by
-
Postbiotics as Mitochondrial Modulators in Inflammatory Bowel Disease: Mechanistic Insights and Therapeutic Potential.Biomolecules. 2025 Jul 1;15(7):954. doi: 10.3390/biom15070954. Biomolecules. 2025. PMID: 40723826 Free PMC article. Review.
References
-
- Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol. 2018;11:1–10. - PubMed
-
- Kim DH, Park J, Kim S, et al. An Escherichia coli strain with extra catalase activity protects against murine colitis by scavenging hydrogen peroxide and regulating regulatory t cell/interleukin-17 pathways. Free Radic Biol Med. 2021;174:110–120. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources